Indication · GI, Urology & Nephrology
Kidney failure and dialysis
Last checked: Nov 19, 2026Source: FDA, ClinicalTrials.gov
Devices
870
Cleared or approved since 2000
PMA and De Novo
20
Higher-risk or first-of-kind devices
Breakthrough devices
7
Authorized through June 30, 2026
Recruiting device trials
100
989 device trials in all
Breakthrough-designated devices
- VasQLaminate Medical Technologies · 2026
- WRAPSODY® Cell-Impermeable EndoprosthesisMerit Medical Systems, Inc. · 2025
- JMS CAVEO A.V. Fistula Needle SetJMS North America Corporation · 2025
4 more devices with a free account
Devices
870 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- IN.PACT AV Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon
Medtronic Vascular, Inc. · PMA · Drug-Coated Peripheral Transluminal Angioplasty Catheter · newest 2024 · 8 decisions
- GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface
W. L. Gore & Associates, Inc. · PMA · System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment · newest 2022 · 7 decisions
- Covera Vascular Covered Stent
C.R. Bard, Inc. · PMA · System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment · newest 2022 · 5 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
Chungnam National University HospitalAcademic, hospital or other
NCT07947485 · 40 participants (planned) · Start Nov 12, 2026 · Primary completion Nov 30, 2027
Device: Six-channel wearable ECG patch (SHC-U8) · For: Hyperkalemia; End-Stage Kidney Disease (ESKD); Hemodialysis
Sites: Daejeon, South Korea
Diality Inc.Not on our public-company list
NCT06613568 · 50 participants (planned) · Start Oct 6, 2025 · Primary completion Mar 2027
Device: Moda-flx Hemodialysis System™ · For: End Stage Kidney Disease
Sites: San Dimas, California; New Hyde Park, New York; Knoxville, Tennessee · 6 sites in all
Seoul National University HospitalAcademic, hospital or other
NCT05575024 · 98 participants · Start Jan 1, 2024 · Primary completion Dec 26, 2025
Device: oXiris membrane; Polysulfone membrane · For: Acute Kidney Injury Due to Sepsis
Sites: Seoul, South Korea
986 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)159
- Catheter, Hemodialysis, Implanted (MSD)102
- Subsystem, Water Purification (FIP)79
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder) (KPO)56
- Enzymatic Method, Creatinine (JFY)33
- System, Perfusion, Kidney (KDN)33
- Needle, Fistula (FIE)29
- Set, Tubing, Blood, With And Without Anti-Regurgitation Valve (FJK)26
- Alkaline Picrate, Colorimetry, Creatinine (CGX)22
- Accessories, Blood Circuit, Hemodialysis (KOC)20
- Catheter, Hemodialysis, Non-Implanted (MPB)20
- System, Peritoneal, Automatic Delivery (FKX)18
- Test, Cystatin C (NDY)17
- Albumin, Antigen, Antiserum, Control (DCF)15
- Urease And Glutamic Dehydrogenase, Urea Nitrogen (CDQ)14
- Set, Administration, For Peritoneal Dialysis, Disposable (KDJ)14
- Catheter, Peritoneal, Long-Term Indwelling (FJS)13
- Tank, Holding, Dialysis (FIN)12
- Catheter, Hemodialysis, Triple Lumen, Non-Implanted (NIE)11
- Set, Perfusion, Kidney, Disposable (KDL)10
- System, Hemodialysis, Access Recirculation Monitoring (MQS)8
- Strip, Test, Reagent, Residuals For Dialysate, Disinfectant (MSY)8
- Dialyzer, Capillary, Hollow Fiber (FJI)7
- Indicator Method, Protein Or Albumin (Urinary, Non-Quant.) (JIR)7
- Dialyzer Reprocessing System (LIF)7
- Kit, Repair, Catheter, Hemodialysis (NFK)7
- Urease, Photometric, Urea Nitrogen (CDN)6
- Protector, Transducer, Dialysis (FIB)6
- System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment (PFV)6
- Meter, Conductivity, Non-Remote (FIZ)5
Research
- Device studies on end stage renal disease across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.